Health Care & Life Sciences » Pharmaceuticals | Apeloa Pharmaceutical Co. Ltd.

Apeloa Pharmaceutical Co. Ltd.

Apeloa Pharmaceutical Co. Ltd. A
Stock Exchange Shenzhen Stock Exchange
EPS
CNY0.35
Market Cap
CNY12.04 B
Shares Outstanding
1.15 B
Public Float
533.21 M

Profile

Address
No. 333 Hengdianjiang South Road
Dongyang Zhejiang 322118
China
Employees -
Website http://www.apeloa.com
Updated 07/08/2019
Apeloa Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of active pharmaceutical ingredients, and drug preparation. Its products include levofloxacin hydrochloride, amantadine hydrochloride, ofloxacin, adamantane, and other pharmaceutical ingredients. It also offers capsules, ointment, granules, and injections.

Financials

View All
Created with Highcharts 5.0.14Apeloa Pharmaceutical Co. Ltd. ANet Income. Fiscal year is January-December. All values CNY Millions.1671673223222082082632632572573713712013201420152016201720180100200300400
Created with Highcharts 5.0.14Apeloa Pharmaceutical Co. Ltd. ASales/Revenue. Fiscal year is January-December. All values CNY Millions.3 9003 9004 2334 2334 3374 3374 7294 7295 4995 4996 3306 33020132014201520162017201802k4k6k8k

Fang Meng Zhu
Chairman & General Manager
Wen Cai Xu
Director